Clinical Trials Directory

Trials / Completed

CompletedNCT02093390

A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects

A Phase 1, Open-Label, Drug-Drug Interaction Study to Evaluate the Effects of Multiple Oral Doses of Fluconazole and Atorvastatin on the Pharmacokinetics of a Single Oral Dose of TAK-385 in Healthy Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Millennium Pharmaceuticals, Inc. · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This is a nonrandomized, open-label, fixed-sequence, 2-arm study designed to assess the effect of multiple doses of fluconazole or atorvastatin on the single-dose pharmacokinetics of TAK-385 in healthy adult subjects.

Detailed description

The drug being tested in this study is called TAK-385. TAK-385 was being tested to assess if the way it is processed the body changes when it administered with other medications (fluconazole or atorvastatin). This study looked at lab results in people who took TAK-385. The study enrolled 40 patients. Participants were assigned to one of the two treatment groups: * TAK-385 40 mg and fluconazole 400 mg on Day 6 and 200 mg on Days 7 to 14 * TAK-385 40 mg and atorvastatin 80 mg on Days 6-14 Participants in the fluconazole arm were administered TAK-385 on Days 1 and 10 and fluconazole on Days 6 through 14. Participants in the atorvastatin arm were administered TAK-385 on Days 1 and 10 and atorvastatin on Days 6 through 14. This single-center trial was conducted in the United States. The overall time to participate in this study was 4 weeks. Participants made multiple visits to the clinic, including one 16-day period of confinement to the clinic, and a final visit 7 days after last dose of study drug for a follow-up assessment.

Conditions

Interventions

TypeNameDescription
DRUGTAK-385TAK-385 tablets
DRUGFluconazoleFluconazole tablets
DRUGAtorvastatinAtorvastatin tablets

Timeline

Start date
2014-03-01
Primary completion
2014-04-01
Completion
2014-04-01
First posted
2014-03-21
Last updated
2016-06-06
Results posted
2016-06-06

Source: ClinicalTrials.gov record NCT02093390. Inclusion in this directory is not an endorsement.